Rise in Surgical Procedures Following Adoption of Holmium Laser Enucleation for Prostate Treatment
Introduction of holmium laser enucleation of the prostate (HoLEP) leads to a significant rise in urological surgical procedures, enhancing treatment capacity for benign prostatic hyperplasia.
Recent research indicates that integrating holmium laser enucleation of the prostate (HoLEP) into urology practice significantly boosts surgical case volume for benign prostatic hyperplasia (BPH). A study published in the Journal of Biological Methods on August 20 analyzed the impact of HoLEP's introduction over a five-year period, reviewing electronic health records of 4,390 patients across 30 months before and after its implementation.
Led by Dr. Ankur U. Choksi from Yale School of Medicine, the retrospective study observed no significant change in patient travel distance or residence distribution, suggesting consistent access to care. Notably, the number of surgeries increased markedly from 355 to 1,018 cases, coinciding with the adoption of HoLEP. The study also found that prostate sizes among patients undergoing HoLEP were comparable regardless of geographic location.
The findings highlight the potential benefits of HoLEP for urologists seeking to expand their surgical volume and efficiently treat patients with larger prostates. The authors emphasize that implementing HoLEP can enhance the capacity to serve more patients effectively within existing practice models.
This evidence supports wider adoption of HoLEP in urology practices aiming to improve treatment outcomes and increase procedural throughput. For more detailed information, refer to the primary publication: Ankur U. Choksi et al, "Shifts in clinical practice and patient demographics following the introduction of holmium laser enucleation for benign prostatic hyperplasia in a general urology clinic," Journal of Biological Methods, 2025. DOI: 10.14440/jbm.2025.0002.
Source: https://medicalxpress.com/news/2025-09-surgical-volume-introduction-holmium-laser.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
COVID-19 Surge in California Driven by New 'Stratus' Variant Tied to Omicron
COVID-19 cases are rising quickly in California, driven by the new 'stratus' omicron subvariant, with health officials warning about ongoing community transmission and delayed vaccine rollout. Learn the latest updates from experts.
FDA Approves Innovative Eye Implant to Combat Vision Loss in Rare Retina Disease
The FDA has approved ENCELTO, a groundbreaking eye implant that slows vision loss in patients with macular telangiectasia type 2, offering hope through advanced neuroprotective therapy.
High Noon Recalls Vodka Seltzer Cans Mislabeled as Energy Drinks
High Noon has recalled certain vodka seltzer packs after mislabeling cans as energy drinks, which still contained alcohol. Consumers should check their products and discard any that are mislabeled to prevent accidental alcohol consumption.
Study Reveals 14% of U.S. Adults Begin GLP-1 Receptor Agonist Therapy Post-Bariatric Surgery
A new study shows that 14% of U.S. adults start GLP-1 receptor agonist therapy after bariatric surgery, highlighting its role in metabolic management post-surgery.